Expert Contributor Pulls Support from Channel 4's 'The Great ADHD Myth?', Citing Misrepresentation
Professor Katya Rubia, a cognitive neuroscientist at King's College London's Institute of Psychiatry, Psychology and Neuroscience, has withdrawn her support for Channel 4's documentary 'The Great ADHD Myth?', accusing the programme of cherry-picking, truncating, and presenting her comments out of context to fit a predetermined narrative. Rubia, who contributed to the documentary as an expert, said the programme misrepresented her views and could lead to an increased suicide risk by encouraging parents to take their children off ADHD medication (The Guardian).
The documentary, presented by NHS psychiatrist Dr Max Pemberton, concluded that ADHD was a 'social construct' rather than a medical condition. It followed the experience of a 10-year-old boy, Mason, as he was taken off his ADHD medication on camera. Rubia criticised this approach sharply, calling the 'experiment' nothing but anecdotal evidence — a single case study muddied by a host of uncontrolled variables rather than a reliable scientific test.
Rubia's objections extend beyond the editing of her own contributions. She said ADHD was largely underdiagnosed and undermedicated in the UK, a position directly at odds with the programme's central thesis. She warned that taking children with ADHD off medication could lead to an increase in longer-term adverse outcomes, citing increased anxiety and depression, lower self-esteem, greater risk of substance abuse, suicide, more antisocial behaviour, and poorer academic achievement. She pointed to research showing that most children prefer to be on medication because it gives them better control over their emotions, resulting in more friends and improved relationships.
On the question of alternative treatments, Rubia said substantial research on nutrition, supplements, exercise, neurofeedback (a technique that trains people to regulate their own brain activity), cognitive training, and nature exposure in children with ADHD shows mostly non-significant or very tiny effects, inferior to medication. She also pointed to substantial evidence that long-term use of ADHD medication is associated with benefits including reduced rates of suicide, comorbidities (the presence of additional conditions alongside ADHD), crime, and traffic accidents (The Guardian).
A Channel 4 spokesperson disputed the claim that the programme denied the lived experience of those diagnosed with ADHD, saying it sought to present the views of a range of senior medical experts who question the conventional understanding of ADHD (The Guardian).
Notably, Rubia's position is not uniformly aligned with the conventional neurobiological framing of ADHD either. She has said there is no convincing data that 'ADHD brains' are different from 'normal' brains (The Guardian). The Guardian's review of the documentary, published on 18 August 2026, described it as 'the most controversial show of the year.'
The broader context here is a UK media and policy landscape where ADHD diagnosis and prescribing rates have been the subject of intensifying public debate. Documentaries positioning themselves as skeptical of mainstream psychiatric consensus carry particular weight when they feature practising NHS clinicians like Pemberton and when they broadcast children being taken off prescribed medication. Rubia's withdrawal matters because it removes an expert voice the programme apparently relied on for credibility, and because her critique targets not just the editorial framing but the potential real-world consequences for families who may act on the programme's conclusions.
Rubia's critique also exposes a tension within the scientific discourse on ADHD. Her acknowledgment that neuroimaging has not produced convincing evidence of distinct 'ADHD brains' could be read as sympathetic to elements of the programme's skepticism. Yet she draws the opposite policy conclusion: the absence of clear neurobiological markers does not negate the clinical evidence for medication's efficacy or the harms of withholding treatment. That distinction, between aetiology (the study of what causes a condition) and therapeutic evidence, is where the documentary's framing and the scientific consensus diverge most sharply.
What remains unresolved is whether Channel 4 will address the substance of Rubia's complaints or stand by the editorial process that produced the programme. The spokesperson's statement focused on the programme's intent to present dissenting views, not on the specific allegations of misrepresentation. For clinicians, policymakers, and families navigating ADHD treatment decisions, the dispute points to the distance between a television narrative constructed for impact and the more textured evidence base that informs clinical practice.
